ANG Lifesciences India Limited (BOM:540694)

India · Delayed Price · Currency is INR

29.85

-1.57 (-5.00%)

At close: Aug 17, 2026

ANG Lifesciences India Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	-	928.47	1,461	2,199	3,543	1,544
Revenue Growth	-	-36.45%	-33.55%	-37.94%	129.50%	21.72%
Gross Profit	-	332.24	509.97	693.01	1,263	504.18
Operating Income	-	-72.97	13.78	134.63	618.6	126.57
Net Income	-	-124.13	-101.43	-2.62	403.17	70.28
Earnings Per Share	-	-9.51	-7.77	-0.20	31.11	5.42
EPS Growth	-	-	-	-	473.69%	15.29%

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Pharmaceuticals	899.1	1,314	2,070	3,487	1,544
Printing and Packagings	67.63	183.02	242.05	218.97	-
Inter Segment	-38.27	-35.61	-113.19	-162.65	-
Total	928.47	1,461	2,199	3,543	1,544

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Investments	-	36.36	57.35	61.78	66.52	38.63
Total Debt	-	832.06	728.37	707.48	769.95	431.61
Net Cash (Debt)	-	-795.7	-671.01	-645.71	-703.43	-392.98
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-	-60.93	-51.39	-49.70	-54.28	-30.33

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Cash Flow	-	-2.56	-94.95	263.77	247.17	91.44
Capital Expenditures	-	-37.51	-55.69	-104.45	-413.45	-42.44
Free Cash Flow	-	-40.07	-150.63	159.33	-166.28	49
Free Cash Flow Growth	-	-	-	-	-	53.66%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Gross Margin	-	35.78%	34.90%	31.52%	35.65%	32.66%
Operating Margin	-	-7.86%	0.94%	6.12%	17.46%	8.20%
Pretax Margin	-	-16.91%	-7.33%	1.19%	15.10%	6.57%
Profit Margin	-	-13.37%	-6.94%	-0.12%	11.38%	4.55%
FCF Margin	-	-4.32%	-10.31%	7.25%	-4.69%	3.17%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 18, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
PE Ratio	-	-	-	-	6.03	6.33
P/FCF Ratio	-	-	-	6.23	-	9.08
PS Ratio	-	0.32	0.40	0.45	0.69	0.29